Vitasora Health Limited
VHLUF
$0.01
-$0.05-91.39%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 250.84% | 330.00% | 561.95% | 535.30% | 485.16% |
| Total Other Revenue | -11.14% | -4.03% | 6.34% | 6.34% | 6.34% |
| Total Revenue | 164.42% | 192.57% | 251.48% | 200.15% | 135.35% |
| Cost of Revenue | -161.68% | -148.35% | 1,025.00% | 1,159.34% | 1,160.38% |
| Gross Profit | 228.26% | 233.63% | 248.89% | 185.45% | 103.05% |
| SG&A Expenses | 74.01% | 69.88% | 67.40% | 49.93% | 30.28% |
| Depreciation & Amortization | 13,856.25% | 976.00% | -7.67% | -66.67% | -96.16% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 71.88% | 68.69% | 67.34% | 50.66% | 32.10% |
| Operating Income | -49.21% | -44.10% | -40.32% | -30.28% | -19.29% |
| Income Before Tax | -49.17% | -43.45% | -39.04% | -28.90% | -17.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -49.19% | -43.47% | -39.06% | -28.91% | -17.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -49.19% | -43.47% | -39.06% | -28.91% | -17.84% |
| EBIT | -49.21% | -44.10% | -40.32% | -30.28% | -19.29% |
| EBITDA | -49.87% | -45.32% | -42.11% | -31.69% | -20.06% |
| EPS Basic | -9.52% | -6.98% | -2.22% | 6.38% | 14.29% |
| Normalized Basic EPS | -7.69% | -3.70% | 0.00% | 6.90% | 13.33% |
| EPS Diluted | -4.55% | -2.22% | 2.13% | 6.25% | 10.20% |
| Normalized Diluted EPS | -7.69% | -3.70% | 0.00% | 6.90% | 13.33% |
| Average Basic Shares Outstanding | 41.69% | 39.59% | 37.16% | 36.06% | 34.76% |
| Average Diluted Shares Outstanding | 41.69% | 39.59% | 37.16% | 36.06% | 34.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |